US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 88.720
  • +0.250+0.28%
Close Mar 21 16:00 ET
  • 88.720
  • 0.0000.00%
Post 20:01 ET
5.67BMarket Cap-82.92P/E (TTM)

About Blueprint Medicines Company

Blueprint Medicines Corp. is a precision therapy company, which engages in the provision of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Company Profile

SymbolBPMC
Company NameBlueprint Medicines
Listing DateApr 30, 2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees649
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580
Websitehttp://www.blueprintmedicines.com

Company Executives

  • Name
  • Position
  • Salary
  • Kathryn Haviland
  • Director, President and Chief Executive Officer
  • 6.43M
  • Michael Landsittel, M.B.A.
  • Chief Financial Officer
  • 2.19M
  • Dr. Becker Hewes, M.D.
  • Chief Medical Officer
  • --
  • Tracey L. McCain, Esq.
  • Chief Legal and Compliance Officer
  • --
  • Dr. Philina Lee, PhD
  • Chief Commercial Officer
  • --
  • Christina Rossi, M.B.A.
  • Chief Operating Officer
  • 2.81M
  • Dr. Percy H. Carter, M.B.A.,PhD
  • Chief Scientific Officer
  • 2.30M
  • Dr. Christopher K. Murray, PhD
  • Chief Technical Operations and Quality Officer
  • --
  • Debra Durso-Bumpus
  • Chief People Officer
  • --
  • Ariel Hurley
  • Senior Vice President, Finance and Principal Accounting Officer
  • --
  • Dr. Fouad Namouni, M.D.
  • President, Research and Development
  • 2.80M
  • Jeffrey W. Albers, J.D.
  • Chairman of the Board
  • 526.08K
  • Alexis A. Borisy, A.M.
  • Director
  • 397.33K
  • Dr. John Tsai, M.D.
  • Independent Director
  • 769.80K
  • Dr. Nicholas Lydon, F.R.S.,PhD
  • Independent Director
  • 417.33K
  • Dr. Mark Alan Goldberg, M.D.
  • Independent Director
  • 419.33K
  • Lonnel Coats
  • Independent Director
  • 419.33K
  • Dr. Lynn Seely,M.D.
  • Lead Independent Director
  • 452.33K
  • Daniella Beckman
  • Independent Director
  • 422.33K
  • Habib Joseph Dable
  • Independent Director
  • 412.33K

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

No. Symbol Price
Apple
AAPL
218.270
The Kroger Co.
KR
65.400
VeriSign
VRSN
244.510
4
Citigroup
C
71.980
5
Chevron
CVX
164.750
Log In for the Full List
Unlock Now
Discussing
地產板塊回暖！中國資產能否延續漲勢？
3月17日早盤，地產代理、物業服務及管理等板塊漲幅明顯，貝殼-W早盤漲逾4%，碧桂園服務漲逾9%。政策消息面上，兩部門發文落實專項債支持收地，中房協組織民營房企座談會。中國資產本輪火爆行情還能持續多久？你會如何投資？ Show More
Review on February 27...
focus on technology stocks
Top tech company strong as always.
Investment Course
Beginner's guide to Crypto that you must learn
Beginner's Guide: Understand how to invest in Crypto in 3 minutes.
Crypto (Cryptos) is, in simple terms, a virtual currency based on cryptographic principles to ensure transaction security. Unlike the currencies we use daily, C
Not investing, you won't know! 4 'misunderstandings' about Bitcoin
As the time approaches for President Trump to take office, the "Trump Trade" frenzy is once again driving the cryptocurrency market! There are market rumors tha
Cutting leeks? Unsafe? Answering the 10 'soul-searching questions' for Crypto newcomers.
Q1: Is Cryptocurrency a scam for cutting leeks? NO NO! This is a common misunderstanding about Cryptocurrency by many people. Cryptocurrency is not an invention